Amicus Therapeutics

​​Jeff Castelli, Chief Development Officer

Oct. 12 | 5:00pm | AVROBIO Ballroom

Philadelphia, PA
(NASDAQ: FOLD)

In-person Presentation
Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases, including an industry leading rare disease gene therapy portfolio.
www.amicusrx.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions